Here are three notes:
1. Thomas Schroeppel, MD, will serve as the site’s principal investigator.
2. The INSPIRE study now encompasses 32 clinical sites.
3. The INSPIRE study tests the Neuro-Spinal Scaffold’s efficacy and safety for complete thoracic AIS A spinal cord injury.
More articles on devices:
Intellirod Spine acquires new intellectual property: 5 key points
Spineology earns FDA clearance for Rampart One system: 3 points
FDA clears K2M’s Capri Small 3D Static Corpectomy System: 4 key notes
